[afro-nets] RFI: Studies on HIV-HAART and Diabetes and diabetes complications (2)

["Brian Pazvakavambwa" <PazvakavambwaB@zw.afro.who.int>]

RFI: Studies on HIV-HAART and Diabetes and diabetes complications (2)
--------------------------------------------------------------------

Dear Noku,

The following are references to articles that you may find useful. You will note that some of them are specifically on HAART and diabetes as per your request, but I thought those about AIDS and diabetes may also be useful. 

***********

Angela Norris and H. Michael Dreher, Lipodystrophy Syndrome: The Morphologic and Metabolic Effects of Antiretroviral Therapy in HIV Infection, Journal of the Association of Nurses in AIDS care, Volume 15, Issue 6, , November-December 2004, Pages 46-64.

Manuel P. Revuelta, Cumulative insults to mitochondrial function may promote the emergence of [`]syndrome X' and diabetes mellitus in HIV/HCV co-infected patients, Mitochondrion, Volume 4, Issues 2-3, Mitochondria, HIV and Antiretroviral Therapy, July 2004, Pages 175-184.

Renu G. Jain, Eric S. Furfine, Louise Pedneault, Alex J. White and James M. Lenhard, Metabolic complications associated with antiretroviral therapy, Antiviral Research, Volume 51, Issue 3, , September 2001, Pages 151-177.

Thomas N. Kakuda, Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity, Clinical Therapeutics, Volume 22, Issue 6, Congres national de la Societe francaise de pediatrie et de, June 2000, Pages 685-708.

Andrew M. Tershakovec, Ian Frank and Daniel Rader, HIV-related lipodystrophy and related factors, Atherosclerosis, Volume 174, Issue 1, , May 2004, Pages 1-10.

D. Heather Watts , Rajalakshmi Balasubramanian , Robert T. Maupin, Jr.  , Isaac Delke , Alejandro Dorenbaum , Simone Fiore , Marie-Louise Newell , Jean-Francois Delfraissy , Richard D. Gelber  et al., Maternal toxicity and pregnancy complications in human immunodeficiency virus-infected women receiving antiretroviral therapy: PACTG 316, American Journal of Obstetrics and Gynecology, Volume 190, Issue 2, , February 2004, Pages 506-516.

David Y. Hui, Effects of HIV protease inhibitor therapy on lipid metabolism, Progress in Lipid Research, Volume 42, Issue 2, , March 2003, Pages 81-92.

Renu G. Jain, Eric S. Furfine, Louise Pedneault, Alex J. White and James M. Lenhard, Metabolic complications associated with antiretroviral therapy, Antiviral Research, Volume 51, Issue 3, , September 2001, Pages 151-177.

Debra E. Lyon and Erin Truban, HIV-Related Lipodystrophy: A Clinical Syndrome With Implications for Nursing Practice, Journal of the Association of Nurses in AIDS care, Volume 11, Issue 2, , March-April 2000, Pages 36-42.

Zuhayr T. Madhoun, Dwight B. DuBois, Jonathan Rosenthal, Joann C. Findlay and David C. Aron, Central diabetes insipidus: a complication of herpes simplex type 2 encephalitis in a patient with aids, The American Journal of Medicine, Volume 90, Issue 5, , May 1991, Pages 658-659.

PeterL. Silbert, DIABETES MELLITUS, AIDS, AND NIGHT SWEATS, The Lancet, Volume 334, Issue 8674, , 25 November 1989, Page 1285.

AndrewB. M. Swai, PatrickJ. M. Lyimo, Fulgens Rutayuga and DonaldG. Mclarty, DIABETES MELLITUS MISDIAGNOSED AS AIDS, The Lancet, Volume 334, Issue 8669, , 21 October 1989, Page 976.

J. Vendrell, I. Conget, A. MUÑOZ, J. Vidal and A. Nubiola, DIABETES IN AIDS PATIENTS, The Lancet, Volume 332, Issue 8621, , 19 November 1988, Page 1196.

S Mauss, M Corzillius, E Wolf, A Schwenk, A Adam, H Jaeger, H Knechten, J Goelz, A Goetzenich, for the DAGNÄ Lipantiretroviral therapy study group. Risk factors for the HIV associated lipodystrophy syndrome in a closed cohort of patients after 3 years of antiretroviral treatment. HIV Medicine 2002 3:1 49

WM El-Sadr, CM Mullin, A Carr, C Gibert, C Rappoport, F Visnegarwala, C Grunfeld, SS Raghavan. Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naïve cohort. HIV Medicine 2005 6:2 114

E. M. Evans, F. Nye, N. J. Beeching, G. V. Gill. 'Disappearing diabetes'?resolution of apparent Type 1 diabetes in a patient with AIDS and cytomegalovirus (CMV) infection. Diabetic Medicine 2005 22:2 218

J. M. Petit, M. Duong, D. Masson, M. Buisson, L. Duvillard, J. B. Bour, M. C. Brindisi, F. Galland, M. Guiguet, P. Gambert, H. Portier, B. Vergès. Serum adiponectin and metabolic parameters in HIV-1-infected patients after substitution of nevirapine for protease inhibitors. European Journal of Clinical Investigation 2004 34:8 569

O Andersen, SB Haugaard, JJ Holst, CF Deacon, J Iversen, UB Andersen, JO Nielsen, S Madsbad. Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapy. HIV Medicine 2005 6:2 91

Ruth Larson MSAPRNBC (Adult Nurse Practitioner), Bernadette Capili DNScAPRNBCNP-C (Dean's Distinguished Postdoctoral Research Scientist), Margaret Eckert-Norton MSAPRNBCCDE (MAINSTREAM Faculty Scholar), Joseph P. Colagreco MSAPRNBCNP-C (Adult Nurse Practitioner), Joyce K. Anastasi PhDDrNPFAAN (Helen F. Pettit Professor of Nursing). Disorders of glucose metabolism in the context of human immunodeficiency virus infection. Journal of the American Academy of Nurse Practitioners 2006 18:3 92

Cheryl R Rosenfeld DO, S. Sethu K Reddy, MD. Endocrine and Metabolic Manifestations of HIV Infection and AIDS. Journal of Intensive Care Medicine 2001 16:4 161

S. B. Haugaard, O. Andersen, C. N. Hales, I. Halsall, A. M. Rosenfalck, J. Iversen, S. Madsbad. Hyperproinsulinaemia in normoglycaemic lipodystrophic HIV-infected patients. European Journal of Clinical Investigation 2006 36:6 436

MP Rhoads, CJ Smith, G Tudor-Williams, P Kyd, S Walters, CA Sabin, EGH Lyall. Effects of highly active antiretroviral therapy on paediatric metabolite levels. HIV Medicine 2006 7:1 16


**********

I can send you abstracts of the articles if do not have access to them.

Best regards,

Brian Pazvakavambwa
WHO Regional Office for Africa (WHO AFRO)
HIV Intercountry Support Team for Southern and Eastern Africa
Harare, Zimbabwe
mailto:pazvakavambwab@zw.afro.who.int